evertex fabrinology limited (TPE:1470)

TPE:1470 Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	806.97	788.04	655.22	845.15	894.79	630.76
Revenue Growth (YoY)	15.01%	20.27%	-22.47%	-5.55%	41.86%	-22.91%
Cost of Revenue	623.62	588.66	525.4	670.83	703.67	517.09
Gross Profit	183.36	199.38	129.82	174.32	191.12	113.67
Selling, General & Admin	112.66	111.59	96.62	105.93	112.68	95.21
Operating Expenses	113.01	112.02	96.47	105.94	112.65	95.57
Operating Income	70.35	87.37	33.35	68.38	78.47	18.1
Interest Expense	-0.87	-0.95	-0.9	-0.56	-0.48	-0.55
Interest & Investment Income	16.63	14.74	9.4	8.21	4.44	3.47
Currency Exchange Gain (Loss)	-11.4	17.03	-1.18	13.35	-3.03	-1.84
Other Non Operating Income (Expenses)	-2.41	1.66	1.69	1.73	-0.56	10.59
EBT Excluding Unusual Items	72.29	119.85	42.36	91.11	78.83	29.78
Gain (Loss) on Sale of Investments	0.33	0.33	13.73	-41.11	-1.22	10.15
Gain (Loss) on Sale of Assets	0.43	0.52	1.09	-	1.14	0.9
Other Unusual Items	-	0	-	0.01	-	-
Pretax Income	73.05	120.7	57.18	50	78.75	40.83
Income Tax Expense	14.06	23.39	7.83	17.16	13.55	5.42
Net Income	59	97.31	49.35	32.84	65.2	35.41
Net Income to Common	59	97.31	49.35	32.84	65.2	35.41
Net Income Growth	-10.42%	97.20%	50.25%	-49.63%	84.11%	-53.32%
Shares Outstanding (Basic)	86	86	86	86	86	86
Shares Outstanding (Diluted)	86	86	86	86	86	86
Shares Change (YoY)	0.04%	0.09%	0.00%	-0.05%	0.06%	-0.07%
EPS (Basic)	0.69	1.13	0.58	0.38	0.76	0.41
EPS (Diluted)	0.68	1.13	0.57	0.38	0.76	0.41
EPS Growth	-11.40%	98.25%	50.00%	-50.00%	85.37%	-53.41%
Free Cash Flow	65.03	85.02	110.62	162.2	-1.32	17.67
Free Cash Flow Per Share	0.76	0.99	1.29	1.89	-0.01	0.21
Dividend Per Share	1.010	1.010	0.580	0.450	0.800	0.420
Dividend Growth	74.14%	74.14%	28.89%	-43.75%	90.48%	-47.50%
Gross Margin	22.72%	25.30%	19.81%	20.63%	21.36%	18.02%
Operating Margin	8.72%	11.09%	5.09%	8.09%	8.77%	2.87%
Profit Margin	7.31%	12.35%	7.53%	3.89%	7.29%	5.62%
Free Cash Flow Margin	8.06%	10.79%	16.88%	19.19%	-0.15%	2.80%
EBITDA	115.75	133.64	79.95	116.99	130.4	64.18
EBITDA Margin	14.34%	16.96%	12.20%	13.84%	14.57%	10.17%
D&A For EBITDA	45.41	46.27	46.6	48.61	51.93	46.07
EBIT	70.35	87.37	33.35	68.38	78.47	18.1
EBIT Margin	8.72%	11.09%	5.09%	8.09%	8.77%	2.87%
Effective Tax Rate	19.24%	19.38%	13.70%	34.31%	17.20%	13.27%
Revenue as Reported	806.97	788.04	655.22	845.15	894.79	630.76

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.